Neural Regeneration Research ›› 2018, Vol. 13 ›› Issue (7): 1195-1203.doi: 10.4103/1673-5374.235031

Previous Articles     Next Articles

Houshiheisan and its components promote axon regeneration after ischemic brain injury

Yue Lu1, 2, Flora Hsiang1, 2 Jia-Hui Chang1, 2, Xiao-Quan Yao1, 2, Hui Zhao1, 2, Hai-Yan Zou1, 2, Lei Wang1, 2, Qiu-Xia Zhang1, 2   

  1. 1 School of Traditional Chinese Medicine, Capital Medical University, Beijing, China
    2 Beijing Key Lab of TCM Collateral Disease Theory Research, Beijing, China
  • Received:2018-05-23 Online:2018-07-15 Published:2018-07-15
  • Contact: Qiu-Xia Zhang, M.D.,zqx26@163.com.
  • Supported by:

    This study was supported by the National Natural Science Foundation of China, No. 81373526.

Abstract:

Houshiheisan, a classic prescription in traditional Chinese medicine, contains Flos Chrysanthemi, Radix Saposhnikoviae, Ramulus Cinnamomi,Rhizoma Chuanxiong, Radix et Rhizoma Asari, Radix Platycodonis, Rhizoma Atractylodis macrocephalae, Poria, Rhizoma Zingiberis, Radix Angelicae sinensis, Radix et Rhizoma Ginseng, Radix Scutellariae and Concha Ostreae. According to traditional Chinese medicine theory, Flos Chrysanthemi, Radix Saposhnikoviae, Ramulus Cinnamomi, Rhizoma Chuanxiong, Radix et Rhizoma Asari and Radix Platycodonis are wind-dispelling drugs; Rhizoma Atractylodis macrocephalae, Poria, Rhizoma Zingiberis, Radix Angelicae sinensis and Radix et Rhizoma Ginseng are deficiency-nourishing drugs. A large number of randomized controlled trials have shown that Houshiheisan is effective in treating stroke, but its mechanism of action is unknown. Axonal remodeling is an important mechanism in neural protection and regeneration. Therefore, this study explored the effect and mechanism of action of Houshiheisan on the repair of axons after cerebral ischemia. Rat models of focal cerebral ischemia were established by ligating the right middle cerebral artery. At 6 hours after model establishment, rats were intragastrically administered 10.5 g/kg Houshiheisan or 7.7 g/kg wind-dispelling drug or 2.59 g/kg deficiency-nourishing drug. These medicines were intragastrically administered as above every 24 hours for 7 consecutive days. Houshiheisan,and its wind-dispelling and deficiency-nourishing components reduced the neurological deficit score and ameliorated axon and neuron lesions after cerebral ischemia. Furthermore, Houshiheisan, and its wind-dispelling and deficiency-nourishing components decreased the expression of proteins that inhibit axonal remodeling: amyloid precursor protein, neurite outgrowth inhibitor protein A (Nogo-A), Rho family small GTPase A (RhoA) and Rho-associated kinase 2 (Rock2), and increased the expression of growth associated protein-43, microtubule-associated protein-2, netrin-1, Ras-related C3 botulinum toxin substrate 1 (Rac1) and cell division cycle 42 (Cdc42). The effect of Houshiheisan was stronger than wind-dispelling drugs or deficiency-nourishing drugs alone. In conclusion, Houshiheisan, and wind-dispelling and deficiency-nourishing drugs promote the repair of axons and nerve regeneration after cerebral ischemia through Nogo-A/RhoA/Rock2 and Netrin-1/Rac1/Cdc42 signaling pathways. These effects are strongest with Houshiheisan.

Key words: nerve regeneration, Houshiheisan, wind-dispelling drug, deficiency-nourishing drug, cerebral ischemia, Nogo-A/RhoA/Rock2 signaling pathway, axonal recovery, Netrin-1/Rac1/Cdc42 signaling pathway, neuroprotection, neural regeneration